Damora Therapeutics Q3 EPS $(0.40) Beats $(0.48) Estimate
Benzinga Newsdesk 4 hours ago
NewsEarningsEarnings Beats
Damora Therapeutics (NASDAQ:DMRA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.48) by 16.67 percent. This is a 83.05 percent increase over losses of $(2.36) per share
Damora Therapeutics (NASDAQ:DMRA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.48) by 16.67 percent. This is a 83.05 percent increase over losses of $(2.36) per share from the same period last year.